Error message

Deprecated function: Creation of dynamic property MergeQuery::$condition is deprecated in MergeQuery->__construct() (line 1357 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).

Ajanta Pharma Signs Pact With Prollenium Medical Technologies

Keshav Seth 14 September 2007

Mumbai: Ajanta Pharmaceuticals has signed an licensing contract with Canada-based Prollenium Medical Technologies to exclusively market the latter’s dermal filler ‘Revanesse’ in the Indian market.

A message from Ajanta Pharmaceuticals said that the Prollenium Technologies has its proficiency in “medical aesthetics.”

The note added that revanesse adds volume and polishes out deficiencies in the skin and also helps protect delicate skin areas from maturating.

The company said that the total Indian dermatology market is projected at Rs 1,300 crore.

Ajanta Pharma shares gained more than 8 per cent at Rs 108.95 on the Bombay Stock Exchange (BSE).

Business News:

India Business

Company News

Regions:

Canada